Time-Dependent Changes in Hematoma Expansion Rate after Supratentorial Intracerebral Hemorrhage and Its Relationship with Neurological Deterioration and Functional Outcome
Gaby Abou Karam,
Min-Chiun Chen,
Dorin Zeevi,
Bendix C. Harms,
Victor M. Torres-Lopez,
Cyprien A. Rivier,
Ajay Malhotra,
Adam de Havenon,
Guido J. Falcone,
Kevin N. Sheth,
Seyedmehdi Payabvash
Affiliations
Gaby Abou Karam
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Min-Chiun Chen
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Dorin Zeevi
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Bendix C. Harms
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Victor M. Torres-Lopez
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Cyprien A. Rivier
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Ajay Malhotra
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Adam de Havenon
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Guido J. Falcone
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Kevin N. Sheth
Department of Neurology, Yale University School of Medicine, New Haven, CT 06520, USA
Seyedmehdi Payabvash
Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT 06520, USA
Background: Hematoma expansion (HE) following an intracerebral hemorrhage (ICH) is a modifiable risk factor and a treatment target. We examined the association of HE with neurological deterioration (ND), functional outcome, and mortality based on the time gap from onset to baseline CT. Methods: We included 567 consecutive patients with supratentorial ICH and baseline head CT within 24 h of onset. ND was defined as a ≥4-point increase on the NIH stroke scale (NIHSS) or a ≥2-point drop on the Glasgow coma scale. Poor outcome was defined as a modified Rankin score of 4 to 6 at 3-month follow-up. Results: The rate of HE was higher among those scanned within 3 h (124/304, 40.8%) versus 3 to 24 h post-ICH onset (53/263, 20.2%) (p p p = 0.010), and mortality (p = 0.003) among those scanned within 3 h, as well as those scanned 3–24 h post-ICH (p = 0.043, p = 0.037, and p = 0.004, respectively). Also, in a subset of 180/567 (31.7%) patients presenting with mild symptoms (NIHSS ≤ 5), hematoma growth was an independent predictor of ND (p = 0.026), poor outcome (p = 0.037), and mortality (p = 0.027). Conclusion: Despite decreasing rates over time after ICH onset, HE remains an independent predictor of ND, functional outcome, and mortality among those presenting >3 h after onset or with mild symptoms.